Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Explore how neutrophils shape the immune response in health and disease. This poster highlights neutrophil pathogen defense mechanisms, including phagocytosis, degranulation, and NETosis, as well as neutrophil roles in inflammation and NET-associated pathologies.
DOWNLOAD NOWTriclosan is an antibiotic and antifungal.1,2 It is an inhibitor of E. coli enoyl-acyl carrier protein reductase (FabI) and FabI containing a glycine-to-valine substitution at position 93 (FabIG93V; IC50s = 2 and 10 µM, respectively).1 Triclosan is active against the bacteria M. epidermidis, M. lysodeikticus, S. aureus, S. lactis, and S. haemolyticus (MICs = 0.03, 0.01, 3, 3, and 1 µg/ml, respectively) and the fungi A. fumigatus, C. albicans, and C. tropicalis (MICs = 10 µg/ml for all).2 It also decreases reattachment to dentin chips by, reduces the viability of, and increases lactate dehydrogenase (LDH) secretion from, human SG gingival epithelial cells when used at concentrations of 30, 100, and 500 µM, respectively.3
WARNING This product is not for human or veterinary use.
1. Mechanism of triclosan inhibition of bacterial fatty acid synthesis. The Journal of Biological Chemisty 274(16), 11110-11114 (1999).
2. Antimicrobial spectrum of triclosan, a broad-
3. Triclosan: Cytotoxicity, mode of action, and induction of apoptosis in human gingival cells in vitro. Eur. J. Oral Sci. 106(2 Pt 1), 628-636 (1998).